Видео с ютуба Imfinzi

FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung Cancer

Durvalumab - Imfinzi - All You Need to Know in 2 Minutes.

Durvalumab ( Imfinzi ) for HCC

Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - Lung Cancer

Durvalumab (Imfinzi): How It Works, Benefits, and Side Effects Explained

Mickey and his caregiver, Carla, talk about IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl)

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care? (BMIC-024)

MOA of IMFINZI in 1L mNSCLC

AstraZeneca - IMFINZI Launch

Imfinzi Uses: Guide to Understanding the Many Benefits of this Breakthrough Immunotherapy

MOA of IMFINZI in 1L mNSCLC - Narrated by Debbie Irwin

Imfinzi (durvalumab) plus bevacizumab met endpoints in EMERALD-1 Phase III results in Liver Cancer

Trending in Oncology: Imfinzi Fast Track, Ivonescimab Milestone and more

Durvalumab / Imfinzi (NIAGRA Trial) Defies Odds in MIBC Survival Benefits Beyond Complete Response

Lung Cancer Video Library - Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

The impact of durvalumab on the SCLC treatment landscape

OncTalk 2021 - PDL1 and Imfinzi/Durvalumab

Groundbreaking Cancer Treatment: IMFINZI® Reduces Cancer Recurrence and Death Rates AstraZeneca News

Препарата нет и не будет!!!

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers